20.05.2020 WHO Medical Product Alert N°5/2020 related to falsified “Defibrotide” identified in Australia, Latvia and Saudi Arabia
12.05.2020 Recognition of documents issued by the regulatory authorities of the European Economic Area countries and Great Britain regarding medicinal products manufacture
07.05.2020 Instructions to access online services on licensing have been developed by the State Service of Ukraine on Medicines and Drugs Control
06.05.2020 The updated guidelines “Medicinal Products. Good Manufacturing Practice” and “Medicinal Products. Principles of Good Distribution Practice of active substances for medicinal products for human use” have been adopted in Ukraine
06.05.2020 The updated guidelines “Medicinal Products. Good Manufacturing Practice” and “Medicinal Products. Principles of Good Distribution Practice of active substances for medicinal products for human use” have been adopted in Ukraine.
06.05.2020 WHO Medical Product Alert N 4/2020 related to falsified medicines circulating in the WHO region of Africa
28.04.2020 The Standard of pharmaceutical care “Coronavirus disease “(COVID-19)” has been implemented
14.04.2020 Amendments to the Licensing conditions for conducting economic activity in manufacturing, wholesale and retail trade, import of medicinal products (except for active pharmaceutical ingredients) has been adopted by the Government